Version history

{
  "session_id": "sess_SDA-2026-04-13-gap-pubmed-20260410-165345-41805e1b_20260414-004616",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n# Mechanistically-Specific Hypotheses: Microglial OxPC Neutralization in MS Lesions\n\n## Hypothesis 1: Nrf2-Orchestrated Enzymatic Detoxification via 15-LOX-Dependent OxPC Catabolism\n\n**Title:** Nrf2-15-LOX Axis Drives OxPC Conversion to Pro-Resolving Lipoxins\n\n**Mechanism:** Oxidized phosphatidylcholines activate NRF2 nuclear translocation in microglia via KEAP1 cysteine residue modification (C151). Nrf2 binding to ARE enhancer elements drives transcription of *ALOX15* (encoding 15-lipoxygenase) and *PON1* (paraoxonase-1). 15-LOX then catalyzes oxygenation of oxidized sn-2 fatty acid residues on OxPC, converting pro-inflammatory species (e.g., POVPC, PGPC) into lipoxin A4 and resolvin D1 analogs that actively promote oligodendrocyte survival and myelin repair.\n\n**Key Evidence:** Nrf2 activation by lipid electrophiles including 4-HNE is well-characterized (PMID: 29166220). ALOX15 expression in macrophages drives production of anti-inflammatory lipid mediators from arachidonic acid (PMID: 28842233). Microglia in MS lesions show upregulated Nrf2 target genes in RNA-seq datasets.\n\n**Testable Prediction:** siRNA knockdown of *NRF2* or *ALOX15* in primary mouse microglia will result in accumulation of pro-inflammatory OxPC species (measured by LC-MS/MS) in culture media and impaired conversion to lipoxin A4, with correspondingly reduced neuroprotective conditioned medium activity on co-cultured neurons.\n\n**Target Gene/Protein:** NRF2 / ALOX15 (15-lipoxygenase)\n\n---\n\n## Hypothesis 2: TREM2-APOE Cholesterol Esterification Routes OxPC for Safe Storage or Export\n\n**Title:** TREM2-Mediated OxPC Trafficking to Esterification Prevents Lipotoxicity\n\n**Mechanism:** Following TREM2-mediated recognition and internalization of OxPC, these oxidized lipids traffick to endoplasmic reticulum-associated ACAT1 (SOAT1), which esterifies free cholesterol liberated from OxPC membranes. Esterified cholesterol is either stored in lipid droplets (sequestering potentially reactive species) or exported via ABCA1/APOE-dependent reverse cholesterol transport. This pathway prevents OxPC-driven mitochondrial dysfunction and ceramide accumulation that triggers neuronal ferroptosis.\n\n**Key Evidence:** TREM2 deficiency causes lipid droplet accumulation in microglia (PMID: 29791952). APOE4 genotype increases MS risk and impairs lipid clearance from glia. ABCA1 deficiency causes accumulation of toxic lipid species in macrophages.\n\n**Testable Prediction:** ACAT1 inhibitor (K-604) treatment or *Apoe* knockout in microglia will cause diversion of internalized OxPC toward toxic ceramide synthesis (measured by lipidomics) rather than safe cholesterol esterification, resulting in increased neuronal death in co-culture despite intact phagocytic uptake.\n\n**Target Gene/Protein:** ACAT1 (SOAT1) / APOE\n\n---\n\n## Hypothesis 3: Selective Autophagy Receptor p",
  "tokens_used": "714"
}